| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/02/2001 | US20010010821 For treatment of gastrointestinal disorders |
| 08/02/2001 | US20010010817 Tumor derived carbohydrate binding protein |
| 08/02/2001 | US20010010816 Purified FIV-141 virus; vaccines |
| 08/02/2001 | US20010010815 Adeno-associated vector compositions for expression of factor VIII |
| 08/02/2001 | EP1144607A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | EP1144440A3 Neurotransmitter transporter |
| 08/02/2001 | DE19955352A1 Streptococcus-Proteine und ihre Verwendung Streptococcus proteins and their use |
| 08/02/2001 | DE10003801A1 Gentechnisch hergestellte insulin-sezernierende Surrogatzelle mit physiologischer Glucoseresponsivität Genetically engineered insulin-secreting cell surrogate with physiological Glucoseresponsivität |
| 08/02/2001 | DE10003373A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003372A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003371A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10001377A1 bHLH-Transkriptionsfaktor ASCL3 und diesen enthaltendes Arzneimittel bHLH transcription factor AsCl3 and this medicinal product containing |
| 08/02/2001 | DE10001230A1 Immunisierungsmittel Immunizing agent |
| 08/02/2001 | CA2399109A1 T cell receptor libraries |
| 08/02/2001 | CA2398791A1 Human membrane proteins and polynucleotides encoding the same |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398660A1 Human cyr61 |
| 08/02/2001 | CA2398611A1 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |
| 08/02/2001 | CA2398563A1 Modulation of gene expression in formation of fatty atherosclerotic lesions |
| 08/02/2001 | CA2398554A1 Novel nucleic acids and polypeptides |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398521A1 Compositions and methods for inhibition of hiv-1 infection |
| 08/02/2001 | CA2398462A1 Transgenic plant-based vaccines |
| 08/02/2001 | CA2398411A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2398407A1 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398283A1 Peptide fragments of colostrinin and their use |
| 08/02/2001 | CA2398251A1 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398242A1 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 08/02/2001 | CA2398104A1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | CA2397998A1 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 08/02/2001 | CA2397991A1 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 08/02/2001 | CA2397839A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2397407A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist |
| 08/02/2001 | CA2396920A1 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds |
| 08/02/2001 | CA2396719A1 22 human secreted proteins |
| 08/02/2001 | CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | CA2396454A1 Recombinant attenuation of prrsv |
| 08/02/2001 | CA2395889A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395885A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395872A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395858A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395857A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395838A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2395827A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395816A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | CA2395815A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395811A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395787A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395734A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395693A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395676A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395671A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395666A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395654A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395403A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395398A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395295A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | CA2395178A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394841A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394332A1 Chimeric neuropeptide y receptors |
| 08/02/2001 | CA2394039A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394022A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393954A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393912A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393652A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393618A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393616A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2393002A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392757A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392751A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392438A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392428A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392422A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2392398A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2366828A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 08/01/2001 | EP1120723A2 Identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists and associated pharmacophore models and screening methods |
| 08/01/2001 | EP1120655A2 A method for detecting an aberrant animal-derived prion gene and prion gene modified mouse which exhibits heart anomalies |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1120463A1 Apoptin-associating protein |
| 08/01/2001 | EP1120426A1 Novel g protein-coupled receptors |
| 08/01/2001 | EP1119773A1 Assay for disease related conformation of a protein |
| 08/01/2001 | EP1119772A1 A novel ret-independent signaling pathway for gdnf |
| 08/01/2001 | EP1119632A1 Hypersensitive response elicitor from xanthomonas campestris |
| 08/01/2001 | EP1119631A2 Transgene assay using stable agrobacterium rhizogenes transformation |
| 08/01/2001 | EP1119630A1 Nucleic acid constructs for genetic immunisation |
| 08/01/2001 | EP1119627A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 08/01/2001 | EP1119626A2 Botulinum neurotoxin vaccine |
| 08/01/2001 | EP1119625A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 08/01/2001 | EP1119624A2 Nucleic acids encoding human cide-b protein and polymorphic markers thereof |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119621A2 G-protein coupled receptor proteins |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |